Evidence map›Paper›PMID 38493478›Full record

ArticleCell reports2024

Histone H3.1 is a chromatin-embedded redox sensor triggered by tumor cells developing adaptive phenotypic plasticity and multidrug resistance.

Flavio R Palma, Diego R Coelho, Kirthi Pulakanti, Marcelo J Sakiyama, Yunping Huang, Fernando T Ogata, Jeanne M Danes, Alison Meyer, Cristina M Furdui, Douglas R Spitz and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Epigenetic regulation and ROS signaling in plant stress adaptation: an integrated framework.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

Flavio R PalmaDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA.
Diego R CoelhoDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA.
Kirthi PulakantiVersiti Blood Research Institute of Wisconsin, and Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Marcelo J SakiyamaDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA.
Yunping HuangDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA.
Fernando T OgataDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA.
Jeanne M DanesDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA.
Alison MeyerVersiti Blood Research Institute of Wisconsin, and Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Cristina M FurduiDepartment of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA.
Douglas R SpitzFree Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA 52245, USA.
Ana P GomesMolecular Oncology Program, H. Lee Moffitt Cancer Center, Tampa, FL 33612, USA.
Benjamin N GantnerDepartment of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Sridhar RaoVersiti Blood Research Institute of Wisconsin, and Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
Vadim BackmanDepartment of Biomedical Engineering, Northwestern University McCormick School of Engineering, Evanston, IL 60208, USA.
Marcelo G BoniniDepartment of Medicine, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Chicago, Chicago, IL 60611, USA; Department of Biochemistry and Molecular Genetics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: marcelo.bonini@northwestern.edu.
Robert H. Lurie Comprehensive Cancer Center of Northwestern UniversityNorthwestern University · USMedical College of Wisconsin · USVersiti Blood Center of Wisconsin · USMcCormick (United States) · USMoffitt Cancer Center · USUniversity of Iowa · USWake Forest University · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Sequencing Coordination and Data Analysis CoreP01HL149620 · NHLBI · UNIVERSITY OF ARIZONA · PI GEURTS, ARON M · 2020 to 2024
$11.8M
Technology Development UnitU54CA268084 · NCI · NORTHWESTERN UNIVERSITY · PI Vadim Backman, Daniela E Matei · 2022 to 2026
$10.0M
Studying E-cadherin dynamics during extravasation and metastatic colonizationU54CA261694 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ROGER D KAMM, Vivek Shenoy · 2021 to 2026
$9.1M
Translating buccal nanocytology for lung cancer screening into clinical practiceR01CA225002 · NCI · NORTHWESTERN UNIVERSITY · PI Vadim Backman, HARIHARAN SUBRAMANIAN · 2018 to 2026
$5.0M
A redox-sensitive switch in the macrophage nucleus regulates acute phaseinflammatory injuryR01HL163820 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BONINI, MARCELO G., GANTNER, BENJAMIN N. · 2022 to 2025
$2.3M
Macrophage Redox State in Sterilizing and Injurious InflammationR01AI131267 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONINI, MARCELO G. · 2017 to 2021
$2.1M
Defining GATA4’s Molecular Function in Gastric Cell BiologyR01DK134064 · NIDDK · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI BATTLE, MICHELE A, RAO, SRIDHAR · 2022 to 2025
$2.1M
MNSOD ACETYLATION PROMOTES CANCER STEM CELL PHENOTYPES IN BREAST CANCERR01CA216882 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BONINI, MARCELO G. · 2018 to 2022
$1.9M
Environmental Arsenic in the Subtype Specification of Breast CancerR01ES028149 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BONINI, MARCELO G. · 2018 to 2022
$1.8M
H3 histone oxidation is a new posttranslational modification linking heavy metal-induced metabolic changes and oncegenic epigenetic reprogrammingR01ES035723 · NIEHS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Marcelo G. Bonini · 2024 to 2026
$1.2M
NCI NIH HHS P30 CA086862NCI NIH HHS R01 CA216882NCI NIH HHS R01 CA225002NCI NIH HHS U54 CA261694NHLBI NIH HHS P01 HL149620NHLBI NIH HHS R01 HL163820NIAID NIH HHS R01 AI131267NIDDK NIH HHS R01 DK134064NIEHS NIH HHS P30 ES005605NIEHS NIH HHS R01 ES028149NIEHS NIH HHS R01 ES035723
6 · The paper itself

Abstract

Chromatin structure is regulated through posttranslational modifications of histone variants that modulate transcription. Although highly homologous, histone variants display unique amino acid sequences associated with specific functions. Abnormal incorporation of histone variants contributes to cancer initiation, therapy resistance, and metastasis. This study reports that, among its biologic functions, histone H3.1 serves as a chromatin redox sensor that is engaged by mitochondrial H

Indexed as

Breast NeoplasmsHistonesChromatinDrug Resistance, MultipleFemaleHumansHydrogen PeroxideChromatinHistonesHydrogen Peroxidebreast cancerchemoresistanceCP: Cancerdrug resistanceEMTH3histone variantsmetastasisredoxROSthiol oxidation

Identifiers

PMID38493478
PMCPMC11209755
OpenAlexW4392881865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.